bismuth has been researched along with iridium radioisotopes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, Y; Fujita, M; Hirokawa, Y; Kashimoto, K; Kashiwado, K; Tamamoto, M; Wada, T | 1 |
| Ab Rashid, R; Abdul Razak, K; Abdullah, R; Che Mat, NF; Khairil Anuar, MA; Mat Nawi, N; Mohd Zainudin, NH; Rahman, WN; Sisin, NNT; Tagiling, N; Zainal Abidin, S | 1 |
| Ab Rashid, R; Abdul Razak, K; Abdullah, R; Che Mat, NF; Khairil Anuar, MA; Rahman, WN; Talik Sisin, NN; Zainal Abidin, S | 1 |
3 other study(ies) available for bismuth and iridium radioisotopes
| Article | Year |
|---|---|
Dose-reducing effect of Lipowitz metal-embedded spacers in interstitial brachytherapy for carcinoma of the mobile tongue.
Topics: Alloys; Bismuth; Brachytherapy; Cadmium; Humans; Iridium Radioisotopes; Lead; Mandibular Diseases; Osteoradionecrosis; Radiation Protection; Radiotherapy Dosage; Radium; Thermoluminescent Dosimetry; Tin; Tongue Neoplasms | 1994 |
Radiosensitization Effects by Bismuth Oxide Nanoparticles in Combination with Cisplatin for High Dose Rate Brachytherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bismuth; Brachytherapy; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Female; Humans; Iridium Radioisotopes; Mice; Nanoparticles; NIH 3T3 Cells; Radiation-Sensitizing Agents; Reactive Oxygen Species | 2019 |
Synergetic Influence of Bismuth Oxide Nanoparticles, Cisplatin and Baicalein-Rich Fraction on Reactive Oxygen Species Generation and Radiosensitization Effects for Clinical Radiotherapy Beams.
Topics: Animals; Bismuth; Brachytherapy; Cisplatin; Drug Synergism; Female; Flavanones; Humans; Iridium Radioisotopes; MCF-7 Cells; Mice; Nanoparticles; NIH 3T3 Cells; Radiation-Sensitizing Agents; Reactive Oxygen Species | 2020 |